Elocon vs Fluticasone in Localized Psoriasis (P03197)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
This is an open-label, randomized, parallel-group clinical study. The primary objective is to assess the difference in response rate between mometasone furoate cream 0.1% (once daily) vs fluticasone propionate cream 0.05% (twice daily) by the end of Day 4 and Day 8 in the management of Indian patients with localized psoriasis.
Epistemonikos ID: a1ec33ea460615c728be963334522b9faffba55a
First added on: May 05, 2024